U.S. Court of Appeals for the Federal Circuit, 2011

Aventis Pharma S.A. v. Sandoz Inc.

Aventis Pharma S.A. v. Sandoz Inc.
U.S. Court of Appeals for the Federal Circuit · Decided March 17, 2011

Aventis Pharma S.A. v. Sandoz Inc.

Opinion

NOTE: This order is nonprecedential.

United States Court of AppeaIs for the FederaI Circuit AVENTIS PHARMA S.A. AND SANOFI-AVENTIS U.S., LLC, ' Plaintiffs-Appellants, V. SANDOZ INC., Defen,dant-Appellee.

2011-1123 Appeal from the United States District Court for the District of Delaware in case n0. 09-CV-810, Chief Judge Greg0ry M. Sleet.

ON MOTION Bef0re BRYSON, Circu,it Judge.

0 R D E R The appellants move to stay the briefing schedule in this appeal, pending disposition of a related appeal, Aventis Pharma S.A. u. Hospira, Inc., 2011-1018, -1047.

The appellees 0pp0se. The appellants reply. The appel- lants also move for an extension of time to file their opening brief AVENTlS PHARMA v. SANDOZ 2 Upon consideration thereof, IT Is 0RDERED THAT: (1) The motion to stay the briefing schedule is granted The appellants are directed to inform this court;, within 30 days of the final disposition of 2011-1018, concerning how they believe that this appeal should proceed. The appellees may also respond within that time. (2) The motion for an extension of time is m0ot.

FoR THE CoURT MAR 1 7 2011 lsi Jan Horbaly Date J an Horbaly Clerk cc: George F. Pappas, Esq.

David C. Doyle, Esq. s8 U.8. UiRf B F€I THE t‘.!RG! !IT HAR 1 7 2011 JAN l'|DRBALY CLEH(

Case-law data current through December 31, 2025. Source: CourtListener bulk data.